Evaluation of Cognitive Function in Newly Diagnosed Hypothyroidism Without Comorbidities Using Montreal Cognitive Assessment (MoCA) Scale.

1. Introduction 1.1 Background of Thyroid Disorders 1.2 Importance of Cognitive Function Evaluation 1.3 Overview of Montreal Cognitive Assessment (MoCA) 2. Literature Review 2.1 Cognitive Impairments in Hypothyroidism 2.2 Tools for Cognitive Assessment 2.3 Previous Studies on MoCA and Hypothyroidism 3. Research Methodology 3.1 Study Design 3.2 Participant Selection Criteria 3.3 Data Collection Procedures 3.4 Statistical Analysis Methods 4. Hypothyroidism and Cognitive Function 4.1 Pathophysiology of Hypothyroidism 4.2 Impact on Cognitive Function 4.3 Cognitive Domains Affected 5. Montreal Cognitive Assessment (MoCA) 5.1 Development of MoCA 5.2 Components of the MoCA Scale 5.3 Validity and Reliability 6. Results 6.1 Participant Demographics 6.2 MoCA Scores Analysis 6.3 Comparison with Control Groups 7. Discussion 7.1 Interpretation of Findings 7.2 Implications for Clinical Practice 7.3 Limitations of the Study 7.4 Recommendations for Future Research 8. Conclusion 8.1 Summary of Key Findings 8.2 Contribution to Scientific Knowledge 8.3 Final Remarks

1. How does newly diagnosed hypothyroidism without comorbidities affect cognitive function as measured by the Montreal Cognitive Assessment (MoCA) scale? 2. What specific cognitive domains are most significantly impacted in individuals with newly diagnosed hypothyroidism without comorbidities, and how do these effects compare to a control group as assessed by the MoCA scale?